Alzheimer’s Society and Professor Sir John Hardy respond to results for Alzheimer’s drug lecanemab: A paper published today in The New England Journal of Medicine has shown that lecanemab, a drug being tested in people with early Alzheimer’s disease, showed a statistically significant reduction in cognitive decline – changes in thinking and memory associated with […]
Comment on Alzheimer’s drug lecanemab
